Company intelligence / Profile preview

PocDoc

Cambridge, England, United Kingdompocdoc.co ↗

Ownership: Private
Employees: ~39
Development stage: Commercial

Overview

PocDoc has launched the first smartphone-based at-home cardiovascular lipid test providing a full five-marker lipid panel. The Healthy Heart Check program delivers quantified results in under 10 minutes and integrates with NHS systems. The company is now the leading provider of QRISK3 scores for CVD risk in UK communities. Clinical validation includes CE mark approval for its AI-driven lateral flow reader technology.

Therapeutic areas: Metabolic DisordersCardiovascular
Modalities: DeviceDiagnostic testDigital health platform
Industry: Metabolite Diagnostics

Partnerships

Well Pharmacy (UK-wide rollout of at-home CVD testing)NHS/NHS App integration partnerRoche Diagnostics Startup Creasphere program participantEndeavour Predict CIC partnership for community screening expansion

Beyond the preview

Go deeper on PocDoc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PocDoc.

Explore the full profile